American Society of Hematology 2021 guidelines for management of venous thromboembolism: prevention and treatment in patients with cancer
Background: Venous thromboembolism (VTE) is a common complication among patients
with cancer. Patients with cancer and VTE are at a markedly increased risk for morbidity and …
with cancer. Patients with cancer and VTE are at a markedly increased risk for morbidity and …
Guideline for reversal of antithrombotics in intracranial hemorrhage: a statement for healthcare professionals from the Neurocritical Care Society and Society of Critical …
Background The use of antithrombotic agents, including anticoagulants, antiplatelet agents,
and thrombolytics has increased over the last decade and is expected to continue to rise …
and thrombolytics has increased over the last decade and is expected to continue to rise …
2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart …
PT O'Gara, FG Kushner, DD Ascheim, DE Casey… - Journal of the American …, 2013 - jacc.org
1.1. Methodology and Evidence Review The recommendations listed in this document are,
whenever possible, evidence based. The current document constitutes a full revision and …
whenever possible, evidence based. The current document constitutes a full revision and …
International clinical practice guidelines including guidance for direct oral anticoagulants in the treatment and prophylaxis of venous thromboembolism in patients with …
Venous thromboembolism (VTE) is the second leading cause of death in patients with
cancer. These patients are at an increased risk of develo** VTE and are more likely to …
cancer. These patients are at an increased risk of develo** VTE and are more likely to …
Antithrombotic therapy for VTE disease: antithrombotic therapy and prevention of thrombosis: American College of Chest Physicians evidence-based clinical practice …
Background This article addresses the treatment of VTE disease. Methods We generated
strong (Grade 1) and weak (Grade 2) recommendations based on high-quality (Grade A) …
strong (Grade 1) and weak (Grade 2) recommendations based on high-quality (Grade A) …
Management of massive and submassive pulmonary embolism, iliofemoral deep vein thrombosis, and chronic thromboembolic pulmonary hypertension: a scientific …
Methods A writing group was established with representation from the Council on Peripheral
Vascular Disease and Council on Cardiopulmonary, Critical Care, Perioperative and …
Vascular Disease and Council on Cardiopulmonary, Critical Care, Perioperative and …
[HTML][HTML] International clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer
Background: Guidelines addressing the management of venous thromboembolism (VTE) in
cancer patients are heterogeneous and their implementation has been suboptimal …
cancer patients are heterogeneous and their implementation has been suboptimal …
Antithrombotic therapy for venous thromboembolic disease: American College of Chest Physicians evidence-based clinical practice guidelines
This chapter about treatment for venous thromboembolic disease is part of the American
College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition) …
College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition) …
Acute pulmonary embolism
VF Tapson - Management of Acute Decompensated Heart …, 2005 - api.taylorfrancis.com
The implications of a particular embolic event depend upon the extent of obstruction of the
crosssectional area of the pulmonary arterial bed as well as upon the presence or absence …
crosssectional area of the pulmonary arterial bed as well as upon the presence or absence …
Nadroparin for the prevention of thromboembolic events in ambulatory patients with metastatic or locally advanced solid cancer receiving chemotherapy: a …
G Agnelli, G Gussoni, C Bianchini, M Verso… - The lancet …, 2009 - thelancet.com
Background Clinical trials are needed to assess the clinical benefit of antithrombotic
prophylaxis in patients with cancer who are receiving chemotherapy, since these patients …
prophylaxis in patients with cancer who are receiving chemotherapy, since these patients …